Navigation Links
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of BioAmber Inc. (BIOA)
Date:3/20/2017

NEW YORK, March 20, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the BioAmber Inc. ("BioAmber" or the "Company") (NYSE: BIOA). Such investors are advised to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/bioa.

The investigation concerns whether BioAmber and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

On March 16, 2017 after-market hours, BioAmber revealed disappointing financial results for its 2016 fiscal year, missing its previously issued revenue forecast by $1.3 million. On the conference call, company's President Fabrice Orecchioni, attributed the unfortunate results to "pricing pressures" and "a disruption from a large customer that was expected to purchase 2.8 million of succinic acid in Q4 2016, but due to a technical problem in its manufacturing facility postponed the order to 2017." Following this news, BioAmber stock dropped during intraday trading on March 17, 2017.

If you are aware of any facts relating to this investigation, or purchased BioAmber shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/bioa.  You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484. 

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-bioamber-inc-bioa-300425843.html


'/>"/>
SOURCE Bronstein, Gewirtz & Grossman, LLC
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Origin Agritech Announces Date for Special Meeting of Shareholders
2. Spherix Updates Shareholders
3. BD Announces Webcast of Annual Meeting of Shareholders
4. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Agile Therapeutics, Inc. (AGRX) and Lead Plaintiff Deadline: March 7, 2017
5. Biorem Reports Sale of Securities by Major Shareholders
6. Biostage CEO Provides Mid-Year Update to Shareholders
7. NantKwest Shareholder (NK) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of NantKwest, Inc.; Encourages Investors to Contact the Firm
8. Spherix Releases Update Letter to Shareholders
9. Spherix Moves to Maintain NASDAQ Compliance as Shareholders Approve Reverse Split
10. Asterias Biotherapeutics Announces Intention to Distribute 3.15 Million Warrants to Purchase Common Shares of Asterias to Asterias Shareholders
11. Oxis Chairman And CEO Tells Shareholders Biotech Company Making Substantial Progress With Lead Cancer Drug, Drawing Closer To NASDAQ Listing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... They call it the ... network, a depiction of a system of linkages and connections so complex and ... professor of computer science at Worcester Polytechnic Institute (WPI) and director of the ...
(Date:10/12/2017)... Irvine, ca (PRWEB) , ... October 12, 2017 ... ... for the Surgical Wound Market with the addition of its newest module, US ... the $1.2B market for thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... INDIANAPOLIS , Oct. 11, 2017  VMS BioMarketing, a ... of a nationwide oncology Clinical Nurse Educator (CNE) network, which ... growing need for communication among health care professionals to enhance ... physicians, nurses, office staff, and other health care professionals to ... for breast cancer. ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
Breaking Biology News(10 mins):